Διαφήμιση
σχετικά με: new hiv vaccine breakthroughVaccine CRO Services for HIV. Well-established technology & experienced scientist. Comprehensive and in-depth R&D layout/perfect services for development of HIV Vaccines.
Αποτελέσματα Αναζήτησης
24 Ιουλ 2024 · The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and...
28 Αυγ 2023 · Called PrEPVacc, the trial is testing two vaccines alongside two forms of pre-exposure prophylaxis (PrEP) to test vaccine efficacy while offering protection to prevent the spread of HIV.
14 Μαρ 2022 · The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.
3 Μαΐ 2021 · SCIENCE. The four-decade quest for an HIV vaccine yields new hope. While the reality is far more nuanced than recent hype suggests, a breakthrough strategy is finally offering fresh tools...
6 Μαρ 2024 · Despite 20 years of failures in major HIV vaccine trials, researchers say recent advances have likely, hopefully, put them on the right track to develop a highly effective vaccine.
28 Νοε 2023 · As new prevention tools, such as the drug cabotegravir — which protects people from HIV infection for up to two months after being injected into the body — become more widely available, health...
31 Ιαν 2022 · The first participants have been vaccinated in a Phase 1 clinical trial of an experimental HIV vaccine that utilizes Moderna’s mRNA technology, the company announced last week.
Διαφήμιση
σχετικά με: new hiv vaccine breakthroughVaccine CRO Services for HIV. Well-established technology & experienced scientist. Comprehensive and in-depth R&D layout/perfect services for development of HIV Vaccines.
